|
1. Rohner E, Wyss N, Trelle S, Mbulaiteye SM, Egger M, Novak U, et al. HHV-8 seroprevalence: a global view. Syst Rev 2014; 3:11-18. doi: 10.1186/2046-4053-3-11. 2. Tseng KC, Lin MN, Chu TY, Tsai JP, Su CC. Predictors of seropositivity for human herpesvirus type 8 in patients with mild cirrhosis. Emerg Microbes Infect 2017;6: e45. doi: 10.1038/emi.2017.32. 3. Noaimi AA, Hameedi AD, Abdullah MM, Ibrahim GA, Hassan HG. Association of Human Herpesvirus Type 8 (HHV-8) expression in patients with Kaposi’s sarcoma: A clinico-immunohistochemical study. J Pak Assoc Dermatol 2023; 33:1446-53. 4. Balada E, Ramentol M, Felip L, Ordi-Ros J, Selva-O'Callaghan A, Simeon-Aznar CP, et al. Prevalence of HHV-8 in systemic autoimmune diseases. J Clin Virol 2015; 62:84-88. doi: 10.1016/j.jcv.2014.11.022. 5. Zhang T, He N, Ding Y, Crabtree K, Minhas V, Wood C. Prevalence of human herpesvirus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China. Clin Microbiol Infect 2011; 17:395-401. doi: 10.1111/j.1469-0691.2010. 03287.x. 6. Zghair AN, Kasim SF, Mohammed NS, Sharma AK. Seroprevalence and Biomarkers Detection of Human Herpes Virus (HHV-8) in Patients with Kaposi Sarcoma. J Tech 2023; 5:141-46. doi: 10.51173/jt. v5i2.857. 7. Jalilvand S, Shoja Z, Mokhtari-Azad T, Nategh R, Gharehbaghian A. Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer 2011; 6:1-6. doi: 10.1186/1750-9378-6-5. 8. Gras J, Helary M, Carette D, Minier M, Salmona M, Gabassi A, et al. Prevalence, Risk Factors, and Shedding of Human Herpes Virus-8 Among Men Having Sex with Men Enrolled in a Pre-Exposure Prophylaxis Study. Clin Infect Dis 2023; 502:1-7. doi: 10.1093/cid/ciad502. 9. Tung YC, Ke LY, Tsai SM, Lu PL, Tsai WC. High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus. Int J Rheum Dis 2013; 16:709-14. doi: 10.1111/1756-185X.12193. 10. Atamna A, Yahav D, Hirzel C. Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients. Transpl Int 2023; 36:1-12. doi: 10.3389/ti.2023.11856. 11. Ferrarese A, Zanetto A, Gambato M, Bortoluzzi I, Nadal E, Germani G, et al. Liver transplantation for viral hepatitis in 2015. World J Gastroenterol 2016; 22:1570-80. doi: 10.3748/wjg. v22.i4.1570. 12. Welker MW, Zeuzem S. Pre-and post-transplant antiviral therapy (HBV, HCV). Visc Med 2016; 32:105-09. doi: 10.1159/000445152. 13. Alborzi A, Hashempour T, Moayedi J, Musavi Z, Pouladfar G, Merat S. Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients. Med Microbiol Immunol 2017; 206:165-74. doi: 10.1007/s00430-017-0497-y. 14. Hashempoor T, Alborzi AM, Moayedi J, Ajorloo M, Bamdad T, Sharifi AH, et al. A Decline in Anti-Core+ 1 Antibody Titer Occurs in Successful Treatment of Patients Infected with Hepatitis C Virus. Jundishapur J Microbiol 2018;11: e58294. doi: 10.5812/jjm.58294. 15. Chou A, Huang W, Lin M, Su C. Human herpesvirus type 8 in patients with cirrhosis independent of thrombocytopenia. J Clin Pathol 2010; 63:254-58. doi: 10.1136/jcp.2009.071621. 16. Martini S, Tandoi F, Romagnoli R, Rizzetto M. Liver transplantation in hepatitis B/hepatitis D (delta) virus coinfected recipients. Transplantation 2022; 106:1935-39. doi: 10.1097/TP.0000000000004138. 17. Mahmud S, Akbarzadeh V, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses. Sci Rep 2018; 8:150. doi: 10.1038/s41598-017-18296-9. 18. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iran Med 2000; 3:192-201. 19. Sarvari J, Mansouri M, Hashempoor T, Hosseini SY, Moattari A, Pirbonyeh N, et al. Association of genotype and haplotype of IL-28B Gene with Hepatitis C infection outcome in iran: Spontaneous clearance versus chronic infection. Hepat Mon 2017;17: e45745. doi: 10.5812/hepatmon.45745. 20. Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon 2016;16: e35577. doi: 10.5812/hepatmon.35577. 21. Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006; 355:1331-38. doi: 10.1056/NEJMoa055009. 22. Zavitsanou A, Sypsa V, Petrodaskalaki M, Kalapothaki V, Whitby D, Hatzakis A. Human herpesvirus 8 (HHV‐8) infection in healthy urban employees from Greece: Seroprevalence and associated factors. J Med Virol 2007; 79:591-96. doi: 10.1002/jmv.20812. 23. Chou AL, Huang WW, Tsao SM, Li CT, Su CC. Human herpesvirus type 8 in patients with cirrhosis: correlation with sex, alcoholism, hepatitis B virus, disease severity, and thrombocytopenia. Am J Clin Pathol 2008; 130:231-37. doi: 10.1309/4FMBN316N4792UQ4. 24. Su CC, Tseng KC, Lin MN, Hsieh TC, Chu TY. High seroprevalence of human herpesvirus type 8 in patients with hepatocellular carcinoma. Eur J Clin Microbiol Infect Dis 2015; 34:55-62. doi: 10.1007/s10096-014-2206-8. 25. Wang W, Gehris BT, Mai B, Chen L, Hu S, You MJ, et al. HHV8-Negative Effusion-Based lymphoma in a patient with recurrent HCV hepatitis status post liver transplantation. Leuk Lymphoma 2022; 63:3480-83. doi: 10.1080/10428194.2022.2123233. 26. Ozaki Y, Tajiri H, Tanaka-Taya K, Mushiake S, Kimoto A, Yamanishi K, et al. Frequent detection of the human herpesvirus 6-specific genomes in the livers of children with various liver diseases. J Clin Microbiol 2001; 39:2173-77. doi: 10.1128/jcm.39.6.2173-2177.2001. 27. Li JC. Reactivation of human herpesvirus (HHV) 6 as etiology of acute liver injury in drug reaction with eosinophilia and systemic symptoms (dress) syndrome: a case report. Cureus 2022; 14:1-7. doi: 10.7759/cureus.29697. 28. Khademolhosseini F, Malekhosseini S, Salahi H, Nikeghbalian S, Bahador A, Lankarani KB, et al. Outcome and characteristics of patients on the liver transplant waiting list: Shiraz experience. Middle East J Dig Dis 2009; 1:63-67. 29. Cohen GM, Langer AL, Sima H, Chang C, Troy K, Taimur S. Hemophagocytic lymphohistiocytosis due to primary HHV-8 infection in a liver transplant recipient. Transplant Direct 2018; 4:411-14. doi: 10.1097/TXD.0000000000000850. 30. Hashempour A, Moayedi J, Musavi Z, Ghasabi F, Halaji M, Hasanshahi Z, et al. First report of HHV-8 viral load and seroprevalence of major blood-borne viruses in Iranian patients with systemic sclerosis. Mult Scler Relat Disord 2021; 51:102872. doi: 10.1016/j.msard.2021.102872. 31. Light TP, Brun D, Guardado-Calvo P, Pederzoli R, Haouz A, Neipel F, et al. Human herpesvirus 8 molecular mimicry of ephrin ligands facilitates cell entry and triggers EphA2 signaling. PLoS Biol 2021;19: e3001392. doi: 10.1371/journal.pbio.3001392. 32. Liu CY, Chen BJ, Chuang SS. Primary effusion lymphoma: a timely review on the association with HIV, HHV8, and EBV. Diagnostics 2022; 12:713-31. doi: 10.3390/diagnostics12030713. 33. Meidani M, Aminzadeh Z, Faghih M, Ahmadi N. Are the preventive services for HHV-8 necessary in HIV positive persons in central zone of Iran? Iran J Pathol 2014; 9:133-37. 34. Gharehbaghian A, Zaghal A, Farhadi Langerudi M, Karimi G. Seroepidemiology of the human Herpesvirus (HHV-8) in the haemodialysis patients’ blood donors and HIV-positive individuals in City of Tehran. J Sch Public Health Inst Public Health Res 2006; 4:57-63. 35. Copeland MMM, Trainor J, Cash WJ, Braniff C. Fatal donor-derived Kaposi sarcoma following liver transplantation. BMJ Case Rep 2021;14: e236061. doi: 10.1136/bcr-2020-236061.
|
